2-DG drug
- Hyderabad
MSN Labs enters into license agreement with DRDO for 2-DG
Hyderabad: MSN Laboratories Pvt. Ltd on Friday announced that it has entered into a license agreement with Defence Research & Development Establishment (DRDE), Institute of Nuclear Medicine and Allied Sciences (INMAS) establishments…
- India
DRDO issues directions on usage of anti-COVID drug 2-DG
New Delhi: The DRDO on Tuesday issued directions on the usage of its 2-DG drug on COVID-19 patients, stating that caution should be exercised while prescribing this medicine to people who have…